U.S. Cannabis Testing Market

U.S. Cannabis Testing Market is valued at USD 1.5 Billion in 2021 and expected to reach USD 3.21 Billion by 2028 with a CAGR of 11.5% over the forecast period.

U.S. Cannabis Testing Market: Size, Trends, Competitive, And Historical & Forecast Analysis, 2022-2029: Throughout the course of the projected timeframe, market growth is anticipated to be driven by a rise in the usage of cannabis for medical purposes and in other legalized contexts, as well as by an expansion in testing facilities and expenditures in research and development activities.

Scope-

Cannabis testing is detecting active components and key chemical constituents in a marijuana specimen. This screening also includes the identification of fungus and bacteria, both of which may cause diseases if left untreated. Cannabinoids and terpenes are the key active elements in marijuana that have therapeutic properties. The specimen contains a high proportion of an effective component.

Cannabis screening is carried out using analytical techniques like gas chromatography, liquid chromatography, and spectrometry; professional laboratories in the area provide marijuana testing facilities. The presence of pesticide residues in a specimen characterizes its cleanliness and effectiveness. Cannabinoids and terpenes are the key active elements in marijuana that have therapeutic properties. The sample contains a high proportion of a therapeutic component.

COVID-19 Impact-

The influence of the COVID-19 outbreak on the marijuana screening sector in the United States has been reported to be positive. Marijuana testing remained in a few jurisdictions, particularly California and New York, throughout the COVID-19 shutdown. A study was performed to examine cannabis for medical and COVID-19 therapeutic objectives.

Additionally, the effectiveness of cannabis extraction needs larger-scale verification, and the study team intends to perform future investigations on their unique rich Cannabidiol C. Sativa varieties. The components might be utilized as a mouthwash as well as neck gargle to avoid COVID-19 illness, based on the testing findings.

Key Players-

The major players characterizing the competitive terrain of this market are -

• SC Labs
• ACS Laboratory
• CannaSafe
• Cascadia Labs
• CB Labs
• CW Analytical
• Steep Hill Labs
• Deibel Laboratories
• Digipath
• Cannalysis
• Encore Labs
• EVIO Labs
• Gobi Labs
• Kaycha Labs
• MCR Lab
• PharmLabs
• Green Leaf Lab
• ProVerde Labs
• The Werc Shop
• others

Segmentation-

By Test Type:

• Pesticide Screening
• Potency Testing
• Heavy Metal Testing
• Residual Solvent Screening
• Mycotoxin Testing
• Terpene Testing

By Technology:

• Chromatography

  • Gas Chromatography
  • Liquid Chromatography

• Spectroscopy

  • Atomic Spectroscopy
  • Mass Spectrometry

Market Drivers:

Increasing Prevalence Of Chronic Illness such as Parkinson’s Disease and Rising regulatory requirements Are Expected To Propel Market Growth Over The Forecast Period:

According to the National Institute of Neurological Disorders and Stroke information on Parkinson's disease, in July 2022, approximately 500,000 individuals in the United States have been identified with Parkinson's; nevertheless, some estimates suggest that all 1 million Americans possess Parkinson's illness and go undetected due to untreated or misdiagnosed troubles. CBD compounds produced from cannabis are utilized to alleviate certain indications of neurological illnesses such as Parkinson's. These high levels of occurrence are likely to boost industrial development.

The industry is rising due to an increase in regulatory requirements, technical developments, and investigation trial activities. For example, Agilent Technologies confirmed the release of the Agilent 6560C Ion Mobility LC/Q-TOF in November 2021, a liquid chromatography/mass spectrometry apparatus that would complement the VWorks automated software package and innovative AssayMAP cartridges with big capacities. This will enhance protein and peptide identification, allowing for faster creation of innovative protein-based therapeutics.

Increasing Product Development, Technology Improvements, and Facility Expansion Sector Are Some Factors Expected To Propel Market Development:

Furthermore, the increasing number of product releases is driving the market's expansion. Other variables, like increased cannabis expenditure, drive industry expansion. This area is seeing several significant advances, technical improvements, partnerships, and collaborations. For example, in August 2022, SC Labs announced the merger of Can Lab, Botanacor, and Agricor into one business known as SC Labs. This startup will offer integrated marijuana testing facilities in Colorado, California, Oregon, and Michigan, as well as worldwide hemp certification.

BelCosta Labs, a renowned California third-party marijuana testing lab, said that it would extend its operations outside California on November 30, 2022. BelCosta is acquiring US Cannalytics ("USC") and Pinnacle CT Laboratories ("PCT"), 2 autonomous screening labs. PCT officially serves Maryland, whereas USC serves New Jersey, Florida, and Pennsylvania. BelCosta Labs will become the new name for all labs. Thus, such developments are expected to contribute to the U.S. Cannabis testing market expansion over the projected period.

The combination brings together over 10 years of cannabis-specific advanced analytical knowledge from five separate state marketplaces to form a nationwide laboratory company that is focused on quality, accountability, and development. The innovative lab division is poised to lead the transformation of the cannabis screening business by giving owners, physicians, and customers precise and reliable data to better comprehend the cannabis encounter.

Market Restraints:

High Initial Investment, Constant Technology Upgradation, Stringent Government Approvals and Regulatory Compliance Are Among the Major Factors Expected To Hinder Market Growth:

One of the most significant hurdles in the market is the expensive start-up expenses for marijuana testing facilities. These labs must make large expenditures in purchasing and maintaining expensive, cutting-edge diagnostic technology. Standardization and modifications of technology, software specifications, accreditations and licenses (including ISO certification processes), and the need for qualified experts all contribute to the operating costs.

States have awarded thousands of permits to potential labs eager to test cannabis substances. Nevertheless, only a tiny percentage of those approved facilities are capable of conducting cannabis testing. Compliance is one of the most serious concerns that many labs encounter. Although legislative concerns and comprehending state standards remain significant hurdles, getting the necessary technology and fine-tuning processes was regarded as the most difficult barrier which is expected to hinder the market development.

News-

Steep Hill is Expanding into Vermont alongside a New Licencing Partnership

On May 11^th, 2022; Steep Hill, a pioneer in cannabis forensic analysis and the first professional cannabis laboratory in the United States, is expanding into Vermont alongside a new licensing partnership. Vermont legalized cannabis for therapeutic use in 2004, and Vermont declared the 11th state to permit adult-use retail in 2020. Steep Hill Vermont, the licensees, is the only analytics facility to get pre-approval from the Government of Vermont.

Trichome Analytical Received The State's First Yearly Licence For Testing Under The State's Emerging Adult-Use Programme

On June 23^th, 2022; Trichome Analytical, New Jersey's first recognized cannabis and hemp testing facility, has received the state's first yearly license for testing under the state's emerging adult-use program. The lab's acquisition of License #TL000001 is an important milestone in the industry's march toward fully operational. With laboratory monitoring in place, the Cannabis Regulatory Commission of New Jersey is expected to begin granting yearly licenses for plant-touching firms like growers and manufacturers.

ACS Laboratory Launched its Own Nationwide Hemp Conformance Testing Board

On August 17^th, 2022; ACS Laboratory, a cannabis testing firm situated in Florida, has established its nationwide hemp conformance testing board. The screen will assist the lab in testing hemp materials for 18 cannabinoids, 24 heavy metals, 105 pesticides, 55 probable residual chemicals, 17 distinct microbes, and every needed mycotoxin, as well as water activity, water content, and terpenes. The panel's formation comes one year after the United States Department of Agriculture (USDA) published official hemp regulations. Numerous states, notably Florida, have now issued their testing guidelines for hemp producers.

Report Analysis	Details
Historical data	2016 - 2021
Forecast Period	2022 - 2029
Market Size in 2021:	USD 1.5 Billion
Base year considered	2021
Forecast Period CAGR %:	11.5%
Market Size Expected in 2028:	USD 3.21 Billion
Tables, Charts & Figures:	175
Pages	300
Companies	SC Labs, ACS Laboratory, CannaSafe, Cascadia Labs, CB Labs, CW Analytical, Steep Hill Labs, Deibel Laboratories, Digipath, Cannalysis, Encore Labs, EVIO Labs, Gobi Labs, Kaycha Labs, MCR Lab, PharmLabs, Green Leaf Lab, ProVerde Labs, and The Werc Shop, among others
Segments Covered	By Test Type, By Technology
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa